Tjerk W.A. de Bruin

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

Erik S.G. Stroes, H A Koomans, Ton J. Rabelink et al. · The Lancet · 1995 · 390 citations

Medicine, Cardiology, Pharmacology +15

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24‐Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study with a 28‐Week Extension

Lawrence A. Leiter, William T. Cefalu, Tjerk W.A. de Bruin et al. · Journal of the American Geriatrics Society · 2014 · 187 citations

Medicine, Pharmacology, Pharmacotherapy +17

Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

William T. Cefalu, Lawrence A. Leiter, Tjerk W.A. de Bruin et al. · Diabetes Care · 2015 · 184 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study

Eva Corpeleijn, Edith J. M. Feskens, Eugène Jansen et al. · Diabetologia · 2006 · 129 citations · Full text

Medicine, Endocrinology, Physiology +17

A Genome Scan for Familial Combined Hyperlipidemia Reveals Evidence of Linkage with a Locus on Chromosome 11

Bradley E. Aouizerat, Hooman Allayee, Rita M. Cantor et al. · The American Journal of Human Genetics · 1999 · 124 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14